Search tips
Search criteria 


Logo of westjmedLink to Publisher's site
West J Med. 1994 December; 161(6): 605–612.
PMCID: PMC1022749

Dietary antioxidants, cancer, and atherosclerotic heart disease.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (1.7M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Chance B, Sies H, Boveris A. Hydroperoxide metabolism in mammalian organs. Physiol Rev. 1979 Jul;59(3):527–605. [PubMed]
  • Halliwell B. Oxidants and human disease: some new concepts. FASEB J. 1987 Nov;1(5):358–364. [PubMed]
  • Tribble DL, Aw TY, Jones DP. The pathophysiological significance of lipid peroxidation in oxidative cell injury. Hepatology. 1987 Mar-Apr;7(2):377–386. [PubMed]
  • Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL. Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med. 1989 Apr 6;320(14):915–924. [PubMed]
  • Witztum JL, Steinberg D. Role of oxidized low density lipoprotein in atherogenesis. J Clin Invest. 1991 Dec;88(6):1785–1792. [PMC free article] [PubMed]
  • Ames BN, Gold LS. Too many rodent carcinogens: mitogenesis increases mutagenesis. Science. 1990 Aug 31;249(4972):970–971. [PubMed]
  • Cohen SM, Ellwein LB. Cell proliferation in carcinogenesis. Science. 1990 Aug 31;249(4972):1007–1011. [PubMed]
  • Preston-Martin S, Pike MC, Ross RK, Jones PA, Henderson BE. Increased cell division as a cause of human cancer. Cancer Res. 1990 Dec 1;50(23):7415–7421. [PubMed]
  • Shigenaga MK, Gimeno CJ, Ames BN. Urinary 8-hydroxy-2'-deoxyguanosine as a biological marker of in vivo oxidative DNA damage. Proc Natl Acad Sci U S A. 1989 Dec;86(24):9697–9701. [PubMed]
  • Park EM, Shigenaga MK, Degan P, Korn TS, Kitzler JW, Wehr CM, Kolachana P, Ames BN. Assay of excised oxidative DNA lesions: isolation of 8-oxoguanine and its nucleoside derivatives from biological fluids with a monoclonal antibody column. Proc Natl Acad Sci U S A. 1992 Apr 15;89(8):3375–3379. [PubMed]
  • Ames BN, Shigenaga MK. Oxidants are a major contributor to aging. Ann N Y Acad Sci. 1992 Nov 21;663:85–96. [PubMed]
  • Dizdaroglu M. Chemical determination of free radical-induced damage to DNA. Free Radic Biol Med. 1991;10(3-4):225–242. [PubMed]
  • Burdon RH, Rice-Evans C. Free radicals and the regulation of mammalian cell proliferation. Free Radic Res Commun. 1989;6(6):345–358. [PubMed]
  • Burdon RH, Gill V, Rice-Evans C. Cell proliferation and oxidative stress. Free Radic Res Commun. 1989;7(3-6):149–159. [PubMed]
  • Sager R. Tumor suppressor genes: the puzzle and the promise. Science. 1989 Dec 15;246(4936):1406–1412. [PubMed]
  • Nigro JM, Baker SJ, Preisinger AC, Jessup JM, Hostetter R, Cleary K, Bigner SH, Davidson N, Baylin S, Devilee P, et al. Mutations in the p53 gene occur in diverse human tumour types. Nature. 1989 Dec 7;342(6250):705–708. [PubMed]
  • Stanbridge EJ. Identifying tumor suppressor genes in human colorectal cancer. Science. 1990 Jan 5;247(4938):12–13. [PubMed]
  • Fearon ER, Cho KR, Nigro JM, Kern SE, Simons JW, Ruppert JM, Hamilton SR, Preisinger AC, Thomas G, Kinzler KW, et al. Identification of a chromosome 18q gene that is altered in colorectal cancers. Science. 1990 Jan 5;247(4938):49–56. [PubMed]
  • Singh VN, Gaby SK. Premalignant lesions: role of antioxidant vitamins and beta-carotene in risk reduction and prevention of malignant transformation. Am J Clin Nutr. 1991 Jan;53(1 Suppl):386S–390S. [PubMed]
  • Burdon RH, Gill V, Rice-Evans C. Oxidative stress and tumour cell proliferation. Free Radic Res Commun. 1990;11(1-3):65–76. [PubMed]
  • Schmidt K. Antioxidant vitamins and beta-carotene: effects on immunocompetence. Am J Clin Nutr. 1991 Jan;53(1 Suppl):383S–385S. [PubMed]
  • Steinbrecher UP, Witztum JL, Parthasarathy S, Steinberg D. Decrease in reactive amino groups during oxidation or endothelial cell modification of LDL. Correlation with changes in receptor-mediated catabolism. Arteriosclerosis. 1987 Mar-Apr;7(2):135–143. [PubMed]
  • Steinbrecher UP. Oxidation of human low density lipoprotein results in derivatization of lysine residues of apolipoprotein B by lipid peroxide decomposition products. J Biol Chem. 1987 Mar 15;262(8):3603–3608. [PubMed]
  • Quinn MT, Parthasarathy S, Fong LG, Steinberg D. Oxidatively modified low density lipoproteins: a potential role in recruitment and retention of monocyte/macrophages during atherogenesis. Proc Natl Acad Sci U S A. 1987 May;84(9):2995–2998. [PubMed]
  • Quinn MT, Parthasarathy S, Steinberg D. Lysophosphatidylcholine: a chemotactic factor for human monocytes and its potential role in atherogenesis. Proc Natl Acad Sci U S A. 1988 Apr;85(8):2805–2809. [PubMed]
  • Berliner JA, Territo MC, Sevanian A, Ramin S, Kim JA, Bamshad B, Esterson M, Fogelman AM. Minimally modified low density lipoprotein stimulates monocyte endothelial interactions. J Clin Invest. 1990 Apr;85(4):1260–1266. [PMC free article] [PubMed]
  • Hessler JR, Robertson AL, Jr, Chisolm GM., 3rd LDL-induced cytotoxicity and its inhibition by HDL in human vascular smooth muscle and endothelial cells in culture. Atherosclerosis. 1979 Mar;32(3):213–229. [PubMed]
  • Henriksen T, Evensen SA, Carlander B. Injury to human endothelial cells in culture induced by low density lipoproteins. Scand J Clin Lab Invest. 1979 Jun;39(4):361–368. [PubMed]
  • Berliner JA, Territo MC, Sevanian A, Ramin S, Kim JA, Bamshad B, Esterson M, Fogelman AM. Minimally modified low density lipoprotein stimulates monocyte endothelial interactions. J Clin Invest. 1990 Apr;85(4):1260–1266. [PMC free article] [PubMed]
  • Rajavashisth TB, Andalibi A, Territo MC, Berliner JA, Navab M, Fogelman AM, Lusis AJ. Induction of endothelial cell expression of granulocyte and macrophage colony-stimulating factors by modified low-density lipoproteins. Nature. 1990 Mar 15;344(6263):254–257. [PubMed]
  • Liao F, Berliner JA, Mehrabian M, Navab M, Demer LL, Lusis AJ, Fogelman AM. Minimally modified low density lipoprotein is biologically active in vivo in mice. J Clin Invest. 1991 Jun;87(6):2253–2257. [PMC free article] [PubMed]
  • Haberland ME, Fong D, Cheng L. Malondialdehyde-altered protein occurs in atheroma of Watanabe heritable hyperlipidemic rabbits. Science. 1988 Jul 8;241(4862):215–218. [PubMed]
  • Ylä-Herttuala S, Palinski W, Rosenfeld ME, Parthasarathy S, Carew TE, Butler S, Witztum JL, Steinberg D. Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man. J Clin Invest. 1989 Oct;84(4):1086–1095. [PMC free article] [PubMed]
  • Palinski W, Rosenfeld ME, Ylä-Herttuala S, Gurtner GC, Socher SS, Butler SW, Parthasarathy S, Carew TE, Steinberg D, Witztum JL. Low density lipoprotein undergoes oxidative modification in vivo. Proc Natl Acad Sci U S A. 1989 Feb;86(4):1372–1376. [PubMed]
  • Salonen JT, Ylä-Herttuala S, Yamamoto R, Butler S, Korpela H, Salonen R, Nyyssönen K, Palinski W, Witztum JL. Autoantibody against oxidised LDL and progression of carotid atherosclerosis. Lancet. 1992 Apr 11;339(8798):883–887. [PubMed]
  • Morel DW, DiCorleto PE, Chisolm GM. Endothelial and smooth muscle cells alter low density lipoprotein in vitro by free radical oxidation. Arteriosclerosis. 1984 Jul-Aug;4(4):357–364. [PubMed]
  • Steinbrecher UP, Parthasarathy S, Leake DS, Witztum JL, Steinberg D. Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids. Proc Natl Acad Sci U S A. 1984 Jun;81(12):3883–3887. [PubMed]
  • de Graaf J, Hak-Lemmers HL, Hectors MP, Demacker PN, Hendriks JC, Stalenhoef AF. Enhanced susceptibility to in vitro oxidation of the dense low density lipoprotein subfraction in healthy subjects. Arterioscler Thromb. 1991 Mar-Apr;11(2):298–306. [PubMed]
  • Tribble DL, Holl LG, Wood PD, Krauss RM. Variations in oxidative susceptibility among six low density lipoprotein subfractions of differing density and particle size. Atherosclerosis. 1992 Apr;93(3):189–199. [PubMed]
  • Chait A, Brazg RL, Tribble DL, Krauss RM. Susceptibility of small, dense, low-density lipoproteins to oxidative modification in subjects with the atherogenic lipoprotein phenotype, pattern B. Am J Med. 1993 Apr;94(4):350–356. [PubMed]
  • Esterbauer H, Gebicki J, Puhl H, Jürgens G. The role of lipid peroxidation and antioxidants in oxidative modification of LDL. Free Radic Biol Med. 1992 Oct;13(4):341–390. [PubMed]
  • Cominacini L, Garbin U, Pastorino AM, Davoli A, Campagnola M, De Santis A, Pasini C, Faccini GB, Trevisan MT, Bertozzo L, et al. Predisposition to LDL oxidation in patients with and without angiographically established coronary artery disease. Atherosclerosis. 1993 Feb;99(1):63–70. [PubMed]
  • Diplock AT. Antioxidant nutrients and disease prevention: an overview. Am J Clin Nutr. 1991 Jan;53(1 Suppl):189S–193S. [PubMed]
  • Gey KF. On the antioxidant hypothesis with regard to arteriosclerosis. Bibl Nutr Dieta. 1986;(37):53–91. [PubMed]
  • Block G. Vitamin C and cancer prevention: the epidemiologic evidence. Am J Clin Nutr. 1991 Jan;53(1 Suppl):270S–282S. [PubMed]
  • Weisburger JH. Nutritional approach to cancer prevention with emphasis on vitamins, antioxidants, and carotenoids. Am J Clin Nutr. 1991 Jan;53(1 Suppl):226S–237S. [PubMed]
  • Ziegler RG. Vegetables, fruits, and carotenoids and the risk of cancer. Am J Clin Nutr. 1991 Jan;53(1 Suppl):251S–259S. [PubMed]
  • Knekt P, Aromaa A, Maatela J, Aaran RK, Nikkari T, Hakama M, Hakulinen T, Peto R, Teppo L. Vitamin E and cancer prevention. Am J Clin Nutr. 1991 Jan;53(1 Suppl):283S–286S. [PubMed]
  • Gey KF, Puska P, Jordan P, Moser UK. Inverse correlation between plasma vitamin E and mortality from ischemic heart disease in cross-cultural epidemiology. Am J Clin Nutr. 1991 Jan;53(1 Suppl):326S–334S. [PubMed]
  • Block G, Patterson B, Subar A. Fruit, vegetables, and cancer prevention: a review of the epidemiological evidence. Nutr Cancer. 1992;18(1):1–29. [PubMed]
  • Enstrom JE, Kanim LE, Klein MA. Vitamin C intake and mortality among a sample of the United States population. Epidemiology. 1992 May;3(3):194–202. [PubMed]
  • Stampfer MJ, Hennekens CH, Manson JE, Colditz GA, Rosner B, Willett WC. Vitamin E consumption and the risk of coronary disease in women. N Engl J Med. 1993 May 20;328(20):1444–1449. [PubMed]
  • Rimm EB, Stampfer MJ, Ascherio A, Giovannucci E, Colditz GA, Willett WC. Vitamin E consumption and the risk of coronary heart disease in men. N Engl J Med. 1993 May 20;328(20):1450–1456. [PubMed]
  • Krinsky NI. Effects of carotenoids in cellular and animal systems. Am J Clin Nutr. 1991 Jan;53(1 Suppl):238S–246S. [PubMed]
  • Donaldson WE. Atherosclerosis in cholesterol-fed Japanese quail: evidence for amelioration by dietary vitamin E. Poult Sci. 1982 Oct;61(10):2097–2102. [PubMed]
  • Smith TL, Kummerow FA. Effect of dietary vitamin E on plasma lipids and atherogenesis in restricted ovulator chickens. Atherosclerosis. 1989 Feb;75(2-3):105–109. [PubMed]
  • Wójcicki J, Rózewicka L, Barcew-Wiszniewska B, Samochowiec L, Juźwiak S, Kadłubowska D, Tustanowski S, Juzyszyn Z. Effect of selenium and vitamin E on the development of experimental atherosclerosis in rabbits. Atherosclerosis. 1991 Mar;87(1):9–16. [PubMed]
  • Williams RJ, Motteram JM, Sharp CH, Gallagher PJ. Dietary vitamin E and the attenuation of early lesion development in modified Watanabe rabbits. Atherosclerosis. 1992 Jun;94(2-3):153–159. [PubMed]
  • Qiao Y, Yokoyama M, Kameyama K, Asano G. Effect of vitamin E on vascular integrity in cholesterol-fed guinea pigs. Arterioscler Thromb. 1993 Dec;13(12):1885–1892. [PubMed]
  • Jialal I, Vega GL, Grundy SM. Physiologic levels of ascorbate inhibit the oxidative modification of low density lipoprotein. Atherosclerosis. 1990 Jun;82(3):185–191. [PubMed]
  • Sato K, Niki E, Shimasaki H. Free radical-mediated chain oxidation of low density lipoprotein and its synergistic inhibition by vitamin E and vitamin C. Arch Biochem Biophys. 1990 Jun;279(2):402–405. [PubMed]
  • Jialal I, Norkus EP, Cristol L, Grundy SM. beta-Carotene inhibits the oxidative modification of low-density lipoprotein. Biochim Biophys Acta. 1991 Oct 15;1086(1):134–138. [PubMed]
  • Esterbauer H, Dieber-Rotheneder M, Striegl G, Waeg G. Role of vitamin E in preventing the oxidation of low-density lipoprotein. Am J Clin Nutr. 1991 Jan;53(1 Suppl):314S–321S. [PubMed]
  • Malone WF. Studies evaluating antioxidants and beta-carotene as chemopreventives. Am J Clin Nutr. 1991 Jan;53(1 Suppl):305S–313S. [PubMed]
  • Smigel K. Dietary supplements reduce cancer deaths in China. J Natl Cancer Inst. 1993 Sep 15;85(18):1448–1450. [PubMed]
  • Steinberg D. Antioxidant vitamins and coronary heart disease. N Engl J Med. 1993 May 20;328(20):1487–1489. [PubMed]
  • Gaziano JM, Manson JE, Buring JE, Hennekens CH. Dietary antioxidants and cardiovascular disease. Ann N Y Acad Sci. 1992 Sep 30;669:249–259. [PubMed]
  • Doll R, Peto R. The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today. J Natl Cancer Inst. 1981 Jun;66(6):1191–1308. [PubMed]
  • Sestili MA. Possible adverse health effects of vitamin C and ascorbic acid. Semin Oncol. 1983 Sep;10(3):299–304. [PubMed]
  • Bendich A, Machlin LJ. Safety of oral intake of vitamin E. Am J Clin Nutr. 1988 Sep;48(3):612–619. [PubMed]
  • Mirvish SS. Effects of vitamins C and E on N-nitroso compound formation, carcinogenesis, and cancer. Cancer. 1986 Oct 15;58(8 Suppl):1842–1850. [PubMed]
  • Rogers AE, Longnecker MP. Dietary and nutritional influences on cancer: a review of epidemiologic and experimental data. Lab Invest. 1988 Dec;59(6):729–759. [PubMed]
  • Gey KF, Brubacher GB, Stähelin HB. Plasma levels of antioxidant vitamins in relation to ischemic heart disease and cancer. Am J Clin Nutr. 1987 May;45(5 Suppl):1368–1377. [PubMed]
  • Comstock GW, Helzlsouer KJ, Bush TL. Prediagnostic serum levels of carotenoids and vitamin E as related to subsequent cancer in Washington County, Maryland. Am J Clin Nutr. 1991 Jan;53(1 Suppl):260S–264S. [PubMed]
  • Blot WJ, Li JY, Taylor PR, Guo W, Dawsey S, Wang GQ, Yang CS, Zheng SF, Gail M, Li GY, et al. Nutrition intervention trials in Linxian, China: supplementation with specific vitamin/mineral combinations, cancer incidence, and disease-specific mortality in the general population. J Natl Cancer Inst. 1993 Sep 15;85(18):1483–1492. [PubMed]
  • Salonen JT, Salonen R, Penttilä I, Herranen J, Jauhiainen M, Kantola M, Lappeteläinen R, Mäenpä PH, Alfthan G, Puska P. Serum fatty acids, apolipoproteins, selenium and vitamin antioxidants and the risk of death from coronary artery disease. Am J Cardiol. 1985 Aug 1;56(4):226–231. [PubMed]
  • Reaven PD, Khouw A, Beltz WF, Parthasarathy S, Witztum JL. Effect of dietary antioxidant combinations in humans. Protection of LDL by vitamin E but not by beta-carotene. Arterioscler Thromb. 1993 Apr;13(4):590–600. [PubMed]
  • Parthasarathy S. Evidence for an additional intracellular site of action of probucol in the prevention of oxidative modification of low density lipoprotein. Use of a new water-soluble probucol derivative. J Clin Invest. 1992 May;89(5):1618–1621. [PMC free article] [PubMed]
  • Bendich A. Safety issues regarding the use of vitamin supplements. Ann N Y Acad Sci. 1992 Sep 30;669:300–312. [PubMed]
  • Keaney JF, Jr, Gaziano JM, Xu A, Frei B, Curran-Celentano J, Shwaery GT, Loscalzo J, Vita JA. Low-dose alpha-tocopherol improves and high-dose alpha-tocopherol worsens endothelial vasodilator function in cholesterol-fed rabbits. J Clin Invest. 1994 Feb;93(2):844–851. [PMC free article] [PubMed]
  • Patterson BH, Block G, Rosenberger WF, Pee D, Kahle LL. Fruit and vegetables in the American diet: data from the NHANES II survey. Am J Public Health. 1990 Dec;80(12):1443–1449. [PubMed]
  • Pryor WA, Prier DG, Church DF. Electron-spin resonance study of mainstream and sidestream cigarette smoke: nature of the free radicals in gas-phase smoke and in cigarette tar. Environ Health Perspect. 1983 Jan;47:345–355. [PMC free article] [PubMed]
  • Church DF, Pryor WA. Free-radical chemistry of cigarette smoke and its toxicological implications. Environ Health Perspect. 1985 Dec;64:111–126. [PMC free article] [PubMed]
  • Anderson R, Theron AJ, Ras GJ. Regulation by the antioxidants ascorbate, cysteine, and dapsone of the increased extracellular and intracellular generation of reactive oxidants by activated phagocytes from cigarette smokers. Am Rev Respir Dis. 1987 May;135(5):1027–1032. [PubMed]
  • Davis WB, Pacht ER, Spatafora M, Martin WJ., 2nd Enhanced cytotoxic potential of alveolar macrophages from cigarette smokers. J Lab Clin Med. 1988 Mar;111(3):293–298. [PubMed]
  • Imbriani M, Melotti A, Ghittori S. Methemoglobin and carboxyhemoglobin levels in smokers and non smokers. G Ital Med Lav. 1987 Jan;9(1):11–14. [PubMed]
  • CALDER JH, CURTIS RC, FORE H. Comparison of vitamin C in plasma and leucocytes of smokers and non-smokers. Lancet. 1963 Mar 9;1(7280):556–556. [PubMed]
  • Brook M, Grimshaw JJ. Vitamin C concentration of plasma and leukocytes as related to smoking habit, age, and sex of humans. Am J Clin Nutr. 1968 Nov;21(11):1254–1258. [PubMed]
  • Schectman G, Byrd JC, Gruchow HW. The influence of smoking on vitamin C status in adults. Am J Public Health. 1989 Feb;79(2):158–162. [PubMed]
  • Schectman G, Byrd JC, Hoffmann R. Ascorbic acid requirements for smokers: analysis of a population survey. Am J Clin Nutr. 1991 Jun;53(6):1466–1470. [PubMed]
  • Tribble DL, Giuliano LJ, Fortmann SP. Reduced plasma ascorbic acid concentrations in nonsmokers regularly exposed to environmental tobacco smoke. Am J Clin Nutr. 1993 Dec;58(6):886–890. [PubMed]
  • Subar AF, Harlan LC, Mattson ME. Food and nutrient intake differences between smokers and non-smokers in the US. Am J Public Health. 1990 Nov;80(11):1323–1329. [PubMed]
  • Grunberg NE. The effects of nicotine and cigarette smoking on food consumption and taste preferences. Addict Behav. 1982;7(4):317–331. [PubMed]
  • Kallner AB, Hartmann D, Hornig DH. On the requirements of ascorbic acid in man: steady-state turnover and body pool in smokers. Am J Clin Nutr. 1981 Jul;34(7):1347–1355. [PubMed]
  • Herbeth B, Chavance M, Musse N, Mejean L, Vernhes G. Dietary intake and other determinants of blood vitamins in an elderly population. Eur J Clin Nutr. 1989 Mar;43(3):175–186. [PubMed]
  • Stryker WS, Kaplan LA, Stein EA, Stampfer MJ, Sober A, Willett WC. The relation of diet, cigarette smoking, and alcohol consumption to plasma beta-carotene and alpha-tocopherol levels. Am J Epidemiol. 1988 Feb;127(2):283–296. [PubMed]
  • Russell-Briefel R, Bates MW, Kuller LH. The relationship of plasma carotenoids to health and biochemical factors in middle-aged men. Am J Epidemiol. 1985 Nov;122(5):741–749. [PubMed]
  • Tangney CC, Stibolt TB, Jr, Zheutlin L, Jacobs E, Hanley M. Comparison of vitamin E levels in plasma, bronchoalveolar lavage, and lung tissues of adult pulmonary patients. J Am Coll Nutr. 1989 Jun;8(3):203–214. [PubMed]
  • Shindo Y, Witt E, Packer L. Antioxidant defense mechanisms in murine epidermis and dermis and their responses to ultraviolet light. J Invest Dermatol. 1993 Mar;100(3):260–265. [PubMed]
  • Fuchs J, Huflejt M, Rothfuss L, Wilson D, Carcamo G, Packer L. Dermatologic antioxidant therapy may be warranted to prevent ultraviolet induced skin damage. Adv Exp Med Biol. 1990;264:533–536. [PubMed]
  • Kagan V, Witt E, Goldman R, Scita G, Packer L. Ultraviolet light-induced generation of vitamin E radicals and their recycling. A possible photosensitizing effect of vitamin E in skin. Free Radic Res Commun. 1992;16(1):51–64. [PubMed]

Articles from The Western Journal of Medicine are provided here courtesy of BMJ Publishing Group